Br J Ophthalmol 1999;83:1324-1328
( December )
Ocular arterial blood flow of choroidal melanoma eyes before and
after stereotactic radiotherapy using Leksell gamma knife: 2 year
follow up
Pia V Vécsei, Karl Kircher, Gunda Nagel, Sabine Toma-Bstaendig, Irene Ruhswurm, Michael Georgopoulos, Martin Zehetmayer
Department of
Ophthalmology, University of Vienna Medical School, Vienna, Austria
Correspondence to: Pia V Vécsei, Department of Ophthalmology, University of Vienna
Medical School, Waehringer Guertel 18-20, A 1090 Vienna, Austria
Accepted for publication 29 June 1999
AIMS
To evaluate the
effect of high dose stereotactic radiotherapy on the ocular blood flow
of patients with uveal melanoma.
METHODS
Colour Doppler
imaging (CDI) was used to measure blood flow velocity and vascular
resistance in the ophthalmic, short posterior, and central retinal
arteries of nine patients suffering from uveal melanoma. The
measurements were taken before, 6 months, 1 year, and 2 years after
stereotactic radiotherapy. Irradiation was performed with the Leksell
gamma knife with the 59 (41-66.5) Gy total marginal dose divided in
two equal fractions. CDI results were compared with age and sex matched
healthy control eyes.
RESULTS
At each time
of measurement, blood flow velocity in the central retinal artery of
the affected eyes was significantly reduced whereas vascular resistance
was only increased at the 2 year follow up. Blood flow velocity and
vascular resistance in the short posterior arteries of melanoma eyes
were also only significantly altered at the 2 year follow up. Blood
flow velocity and vascular resistance in the ophthalmic artery of
melanoma eyes were not changed at all follow ups.
CONCLUSIONS
In the
melanoma eyes, blood flow velocity in the central retinal artery is
reduced. High dose stereotactic radiotherapy with the Leksell gamma
knife and a 59 (41-66.5) Gy total marginal dose in two fractions leads
to a significant reduction of blood flow and a significant increase in
resistance variables in the small ocular arteries within 2 years.
© 1999 by British Journal of Ophthalmology